How Centene Pays
Centene's analytical C1 to C4 and M1 to M4 ladder priced across 21 verified US markets, with 60/40 PSU and RSU executive equity, a quarterly ESPP at 95 percent of market price, a $19.51M CEO package at 206:1, and 96 H-1B records but no verified overseas workforce.
Band Hierarchy
Centene publishes named executive titles, individual job titles and a salary range on each posting. It publishes no universal band numbering, no job-family point system and no individual-contributor to management equivalency table. The C1 to C4 and M1 to M4 levels here are an analytical catalogue built from thirteen current Centene postings and the 2025 visa wage file; only the named executive rows carry a company disclosure.
Individual-contributor ladder — C1 through C4
Management ladder — M1 through M4
Executive — named executive officers
Disclosed executive layer
Track divergence
Hierarchy qualifications and legacy structures
- Centene has never published a band chart, a grade midpoint, a compa-ratio or a range-penetration rule, so nothing in this catalogue should be quoted back as a Centene band. Every level here is an analytical overlay on official postings.
- The bands are most reliable in technology, analytics and clinical operations, where postings and visa records overlap, and least reliable in sales, network contracting and corporate functions, where a single posting is the only evidence.
- WellCare and Health Net remain visible in Centene's locations, titles and leadership biographies, but no public evidence supports a mapping from legacy grade codes to a harmonised Centene framework, so none is asserted here.
- Vice President and Senior Vice President are corporate titles rather than a hidden grade number. The two current vice-president postings differ by $88,100 at the top of range, which is why M4 is shown as an envelope rather than a midpoint.
- The three executive rows are actual fiscal 2025 outcomes for named individuals, not hiring ranges, and they are excluded from the range chart because a $19.5 million accounting total would flatten the employee ladder to a single line.
- Assumed Magellan awards preserve equity for their existing holders only. They do not establish a parallel employee population or a separate current hierarchy.
Peer-level mapping
| Band | Archetype | Peer mapping | Caveat |
|---|---|---|---|
| C1 | Frontline / Coordinator I–II | Coordinator or Analyst I at a managed-care peer; entry professional in technology | Many of these healthcare operations roles are hourly and licence-regulated, so a technology entry-level analogue understates the compliance load.Care Coordinator II posting of 14 August 2026 at $17.84 to $28.02 an hour, annualised at 2,080 hours for a $37,107 to $58,282 envelope. |
| C2 | Coordinator III / Professional I | Analyst II at a managed-care peer; entry to developing individual contributor in technology | The envelope joins a clinical-operations coordinator to an entry technology professional, so the two endpoints are different labour markets rather than one job.Low from the Care Coordinator III posting of 21 August 2026 at $20.39 an hour annualised; high from an official entry-professional ceiling of $101,000. A 2025 Business Analyst II visa record in Irving sits at $82,650. |
| C3 | Senior Professional / Analyst / Engineer | Senior analyst or senior engineer at a managed-care peer; senior individual contributor in technology | Scope varies sharply across the clinical, actuarial, data and technology families, and Centene publishes no family-by-family range.Anchored on the Senior Business Technical Analyst posting of 11 July 2026 at $87,700 to $157,800, with a lower senior-role floor of $70,100. A 2025 Data Analyst IV visa record in Indianapolis sits at $131,330. |
| M1 | Supervisor / Manager / Senior Manager | Supervisor or manager at a managed-care peer; engineering or operations manager in technology | Some Centene manager titles are effectively individual-contributor roles, so the title alone does not establish span of control.Envelope of $63,600 to $199,300 across supervisor and manager postings. The 24 August 2026 Manager of Provider Data Management posting is $70,100 to $126,200 and the 25 August 2026 Senior Manager of Product Performance posting is $107,700 to $199,300. |
| C4 | Lead / Principal / Architect | Lead, principal or architect at a managed-care peer; staff to principal individual contributor in technology | There is no evidence of a single Centene principal ladder, so this row is a cluster of separately posted senior specialist roles.Senior Business Solutions Architect posting of 14 July 2026 at $107,700 to $199,300 and Principal Incident Response Analyst posting of 14 July 2026 at $121,500 to $224,900. 2025 visa records show a Lead Data Engineer in Tampa at $141,267 and Lead Application Development Engineers in St. Louis between $143,750 and $160,496. |
| M2 | Director | Director at a managed-care peer; director in technology | Headcount and profit-and-loss scope vary materially between a plan-operations director and a corporate technology director on the same title.Envelope of $121,500 to $274,200 from official director postings, cross-checked against 2025 visa records at $207,041 for a Director of Information Technology in Tampa and $180,000 for a Director of Operations in Bridgeville. A third-party estimate puts a Director of Operations package at $154,755 base plus $29,726 bonus. |
| M3 | Senior Director | Senior Director at a managed-care peer; senior director in technology | Functional specialty drives a very wide envelope, and a licensed clinical or pharmacy remit can outpay a corporate senior director outright.Senior Director of Healthcare Analytics posting of 20 August 2026 at $134,600 to $249,000 and Senior Director of Pharmacy posting of 12 August 2026 at $185,700 to $352,500, the latter carrying California and licensed-clinical scope. |
| M4 | Vice President / Senior Vice President | Vice President or Senior Vice President at a managed-care peer; vice president in technology | Centene publishes several vice-president ranges rather than one corporate target, so no single VP midpoint can be inferred from any two postings.Envelope of $171,900 to $431,400 across three current vice-president postings: Associate General Counsel at $171,900 to $326,900, Network Development at $180,400 to $343,300 and Interoperability at $227,700 to $431,400. None of the three states a bonus target or an equity grant. |
| E1 | EVP / Chief Officer | Named executive officer or C-suite at a managed-care peer | Total is a grant-date accounting value dominated by stock awards, so it is not cash received and not a hiring range.Median of the three fiscal 2025 named executives carrying a 100 percent bonus target, which is Susan R. Smith as Chief Operating Officer on both salary and total. The cohort spans $3,172,356 for the Chief People Officer to $6,508,793 for the General Counsel. |
| E2 | EVP, Chief Financial Officer | Chief Financial Officer at a managed-care peer | Andrew Asher's 2025 stock award of $13.36 million is close to the chief executive's, so the CFO row is not a simple step below the CEO row.Andrew L. Asher's fiscal 2025 Summary Compensation Table row. His approved 2025 base was $1,200,000, a 17 percent increase and the largest of any named executive. |
| CEO | Chief Executive Officer | Chief Executive Officer at Elevance, Cigna, Molina or UnitedHealth | About 79.7 percent of the reported total is stock awards valued at grant, none of which is guaranteed to be realised.Sarah M. London's fiscal 2025 Summary Compensation Table row. Her approved 2025 base was $1,500,000, a 7 percent increase and her first since 2022. |
Critical evidence warning
Centene publishes no bonus target, no equity grant value and no total-compensation figure for any role below the named executive tier. Its postings state only that total compensation may include additional forms of incentive. This report therefore shows bonus and equity as zero for every employee band rather than estimating a target, and the total column for those bands is base salary alone. Treat the employee rows as a base-salary market map, not as a package.
Compensation by Band — St. Louis
Low / median / high annual values at 1.00× base and 1.00× total-compensation factors versus St. Louis. Total equals base plus bonus plus annualized equity.
| Band | Title | Base | Variable | Total TC | Equity |
|---|---|---|---|---|---|
| C1 | Frontline / Coordinator I–II 0–3 years, role dependent · verified | $41K – $55K | — | $48K $41K – $55K | — |
| C2 | Coordinator III / Professional I 2–4+ years for the cited coordinator role · modeled | $61K – $82K | — | $72K $61K – $82K | — |
| C3 | Senior Professional / Analyst / Engineer 4–7+ years · modeled | $97K – $131K | — | $114K $97K – $131K | — |
| M1 | Supervisor / Manager / Senior Manager 5–10+ years plus people leadership · modeled | $112K – $151K | — | $131K $112K – $151K | — |
| C4 | Lead / Principal / Architect 5–10+ years · modeled | $141K – $191K | — | $166K $141K – $191K | — |
| M2 | Director 8–12+ years · modeled | $168K – $228K | — | $198K $168K – $228K | — |
| M3 | Senior Director 10–15+ years · modeled | $207K – $280K | — | $244K $207K – $280K | — |
| M4 | Vice President / Senior Vice President 10–15+ years of enterprise leadership · modeled | $256K – $347K | — | $302K $256K – $347K | — |
| E1 | EVP / Chief Officer Board and committee appointed · verified | $611K – $826K | 100% | $4.89M $4.15M – $5.62M | $3.58M |
| E2 | EVP, Chief Financial Officer Board and committee appointed · verified | $980K – $1.33M | 150% | $16.07M $13.66M – $18.48M | $13.36M |
| CEO | Chief Executive Officer Board appointed · verified | $1.25M – $1.69M | 200% | $19.51M $16.58M – $22.43M | $15.54M |
Total Compensation Range by Band
Total compensation in St. Louis across the employee bands. Proxy-disclosed executive cohorts are excluded so the employee bands stay readable.
Global Footprint & Pay Arbitrage
Centene reported 61,100 team members at 31 December 2025 and is a domestic United States employer. The current subsidiary exhibit is overwhelmingly domestic, the United Kingdom Circle Health business was sold in January 2024 and the Spanish and Central European operations were divested earlier, so no non-United States employing footprint was verified and none is priced here. St. Louis is the pay anchor.
Office and market catalogue — calibration factors versus St. Louis
| Location | Likely office profile | Presence | Base | TC |
|---|---|---|---|---|
St. Louis United States · USD | Headquarters, enterprise functions, technology and corporate leadership | SEC filings and current job postings | 1.00× | 1.00× |
Clayton United States · USD | Headquarters campus address for the corporate and finance organisation | Verified corporate address in SEC filings | 1.00× | 1.00× |
Tampa United States · USD | Legacy WellCare hub covering technology, operations and health-plan functions | Job postings and 2025 visa worksite records | 1.01× | 1.01× |
Wesley Chapel United States · USD | Tampa Bay technology worksite carrying the highest Florida visa wages in the data | 2025 visa worksite records | 1.19× | 1.19× |
Folsom United States · USD | Northern California technology worksite with the highest observed wage level | 2025 visa worksite records | 1.30× | 1.30× |
Irving United States · USD | Texas analytics and business-analysis worksite, the lowest observed wage level | 2025 visa worksite records | 0.91× | 0.91× |
Indianapolis United States · USD | Indiana health-plan and data organisation, and the site of the employee ICHRA pilot | 2025 visa worksite records and proxy benefit disclosure | 1.00× | 1.00× |
Orlando United States · USD | Florida health-plan operations and member services | Active market in the operating-footprint review | 1.00× | 1.00× |
Charlotte United States · USD | Health-plan and enterprise functions in the Carolinas | Active market in the operating-footprint review | 1.00× | 1.00× |
Chicago United States · USD | Health-plan and care-management operations | Active market in the operating-footprint review | 1.00× | 1.00× |
Atlanta United States · USD | Health-plan and shared enterprise functions in the Southeast | Active market in the operating-footprint review | 1.00× | 1.00× |
Austin United States · USD | Texas health-plan and technology functions | Active market in the operating-footprint review | 1.00× | 1.00× |
Phoenix United States · USD | Arizona health-plan and care-management operations | Active market in the operating-footprint review | 1.00× | 1.00× |
Tempe United States · USD | Arizona operations and technology support | Active market in the operating-footprint review | 1.00× | 1.00× |
Nashville United States · USD | Tennessee health-plan and enterprise functions | Active market in the operating-footprint review | 1.00× | 1.00× |
Sacramento United States · USD | California health-plan operations under state pay-transparency posting rules | Active market in the operating-footprint review | 1.00× | 1.00× |
Woodland Hills United States · USD | Legacy Health Net hub for Southern California plan operations | Active market in the operating-footprint review | 1.00× | 1.00× |
Long Beach United States · USD | Southern California health-plan operations and member services | Active market in the operating-footprint review | 1.00× | 1.00× |
Columbus United States · USD | Ohio health-plan operations | Active market in the operating-footprint review | 1.00× | 1.00× |
Great Falls United States · USD | Montana regional health-plan operations, the smallest verified market | Active market in the operating-footprint review | 1.00× | 1.00× |
Remote / national United States · USD | Remote, hybrid and field roles, the category most Centene postings are advertised under | Every cited 2026 posting names a remote or hybrid work arrangement | 1.00× | 1.00× |
Centene reports total team members in its Form 10-K and nothing by office, state or country, so this catalogue does not rank markets by headcount. The twenty-one entries are the markets the operating-footprint review verified as active, plus the remote and national category that most 2026 postings are advertised under.
St. Louis anchor medians — the basis of every modeled cell
| Band | Base | Stock | Bonus | Other | Total |
|---|---|---|---|---|---|
| C1 | $48K | $0 | $0 | — | $48K |
| E1 | $718K | $3.58M | $514K | $77K | $4.89M |
| E2 | $1.15M | $13.36M | $1.24M | $319K | $16.07M |
| CEO | $1.47M | $15.54M | $2.11M | $386K | $19.51M |
- St. Louis is the anchor because it is the headquarters city and carries the largest single block of observable wage evidence, at 24 of the 96 displayed 2025 labour condition applications with a median of $140,306.
- Centene publishes no city differential schedule at all. Its own stated method is to read the range on the specific posting and the posting's lawful pay-adjustment clause, which is why seventeen of the twenty-one markets here sit at the anchor rather than carrying an invented multiplier.
- Four markets carry an observed factor derived from the 2025 visa medians against the St. Louis median: Folsom at 1.30, Wesley Chapel at 1.19, Tampa at 1.01 and Irving at 0.91. All four samples are small, and Folsom, Wesley Chapel and Irving rest on four to five records each.
- California markets are shown at the anchor even though state pay-transparency law forces Centene to post ranges there, because the only Californian wage observation in the bundle is Folsom, a technology worksite that is not representative of Sacramento, Woodland Hills or Long Beach plan operations.
- The executive rows are enterprise disclosures for named individuals. They do not vary by city and should not be read as a local pay range in any selected market.
Model rules
- Every employee cell is the St. Louis analytical midpoint multiplied by the market's base or total factor. There is no currency conversion in this report because every priced market is in the United States.
- Factors come only from direct wage observations in the 2025 labour condition application file. Where a market has no observation the factor is 1.00, which reflects Centene's stated position that pay is set by the posting rather than by the city.
- A total compensation cell is base plus target bonus plus annualised equity. Because Centene discloses no bonus target and no grant value below the executive tier, total equals base for every band from C1 through M4.
- No employer benefit load is added anywhere in this report. Benefits are economically material at Centene but cannot be valued from the public plan summaries, and loading them into total compensation would turn employer cost into pay.
- Executive rows reconcile exactly to the proxy: salary plus cash incentive plus stock awards plus all other compensation equals the Summary Compensation Table total, with all other compensation carried in its own column.
Variable Pay & Annual Cash Incentive
Centene discloses its executive annual cash incentive in full and discloses nothing about the employee bonus grid. Every current posting says only that total compensation may include additional forms of incentive, with no target percentage, no cadence, no weighting and no payout history. The band rows below therefore record the absence rather than estimating a number.
| Band | Target | Mechanism | Recent payout |
|---|---|---|---|
C1 Frontline / Coordinator I–II | Not publicly disclosed | Postings state that total compensation may include additional incentives, without naming a plan, a target or a cadence. | Not publicly disclosed |
C2 Coordinator III / Professional I | Not publicly disclosed | No enterprise target schedule for individual contributors was located in any filing, plan document or posting. | Not publicly disclosed |
C3 Senior Professional / Analyst / Engineer | Not publicly disclosed | Visa wage records confirm base salary only. Labour condition applications exclude bonus, equity and benefits by construction. | Not publicly disclosed |
C4 Lead / Principal / Architect | Not publicly disclosed | Senior specialist postings carry the same generic incentive language as frontline roles and quantify nothing. | Not publicly disclosed |
M1 Supervisor / Manager / Senior Manager | Not publicly disclosed | No public manager or director target grid was located. Offer documents may differ role by role. | Not publicly disclosed |
M2 Director | Not publicly disclosed | One third-party estimate splits a Director of Operations package into $154,755 of base and $29,726 of bonus, about 19 percent, but it is a modelled estimate on a very broad reported range and is not treated as a Centene target. | Not publicly disclosed |
M3 Senior Director | Not publicly disclosed | Senior director postings disclose base range only, including the California and licensed-clinical roles that carry the widest envelope. | Not publicly disclosed |
M4 Vice President / Senior Vice President | Not publicly disclosed | None of the three current vice-president postings states a target bonus. The first quantified target in the public record is the 100 percent applied to named executive officers. | Not publicly disclosed |
E1 EVP / Chief Officer | 100% of salary | Enterprise annual cash incentive weighted 60 percent adjusted diluted earnings per share, 20 percent organic premium and service revenue growth and 20 percent quality and strategic goals, each paying 0 to 200 percent. | 71.6% of target funded for fiscal 2025, with no individual adjustment |
E2 EVP, Chief Financial Officer | 150% of salary | Same enterprise formula and same funding rate as the other named executives; only the target percentage differs. | 71.6% of target funded, paying $1,238,198 against a $1,729,327 opportunity |
CEO Chief Executive Officer | 200% of salary | Same enterprise formula, capped at 200 percent of target overall. The committee assessed performance and applied no individual adjustment for 2025. | 71.6% of target funded, paying $2,109,446 against a $2,946,154 opportunity |
Executive incentive targets — percent of salary
Named-executive outcomes
| Executive | Target | Paid | Attainment |
|---|---|---|---|
| Sarah M. London | $2,946,154 | $2,109,446 | 71.6% |
| Andrew L. Asher | $1,729,327 | $1,238,198 | 71.6% |
| Christopher A. Koster | $768,269 | $550,081 | 71.6% |
| Susan R. Smith | $718,269 | $514,281 | 71.6% |
| Tanya M. McNally | $654,808 | $468,843 | 71.6% |
Employee payout timing and history
Nothing in the public record supports a broad-workforce payout history. The 71.6 percent rate applies to the named executive plan and must not be projected onto employee bonuses, and Centene has published no companywide salary hike, freeze, cut, campus offer revision or attrition figure for 2025 or 2026. The one enterprise pay event on record is the reverse of a bonus: a voluntary separation program with $315 million to $365 million of estimated severance expense for the rest of 2026.
Sales and special incentives
No sales commission plan, spot bonus schedule, referral award or utilisation-linked incentive was located in any Centene filing, plan exhibit or posting. Network contracting and provider-facing roles are advertised with the same generic incentive sentence as clinical and technology roles, so a sales-style variable structure cannot be inferred from title.
Equity — RSUs, PSUs, Options & ESPP
Centene runs three live share mechanisms and two legacy pools. The 2025 Stock Incentive Plan grants performance share units and restricted stock units to a selected population, the 2002 Employee Stock Purchase Plan lets any eligible employee buy at 95 percent of the quarterly closing price, and legacy Centene and Magellan awards remain outstanding without new grants. No stock options have been granted to employees since 2021.
- A single pool utilisation rate is not determinable from Centene's public tables. Authorised shares, outstanding full-value awards, legacy assumed awards and future availability do not share a one-for-one denominator, and the aggregate table mixes several plans.
- Restricted stock units dominate the outstanding population at roughly 11,548,179 units against about 393,047 options, so Centene's equity overhang is a full-value overhang rather than an option overhang.
- Grant activity in 2025 was roughly 8.836 million restricted stock units granted, 2.593 million vested and 1.047 million forfeited, a gross grant rate far above the vesting rate.
- Fiscal 2025 stock compensation expense was $204 million with a further $356 million unrecognised over about 2.1 years. That is an accounting expense, not a cash pool available for grants.
- About 2,650 employees plus 11 directors held awards at 15 March 2025 against a 61,100 year-end workforce, roughly 4.3 percent. The dates do not match, so treat it as an indicative selectivity signal rather than a participation rate.
Equity plan position at 31 December 2025
Vesting — common reported employee schedule
The one-third-a-year pattern is the executive restricted stock unit schedule disclosed in the proxy. Performance share units follow a different clock entirely: the 2025 cycle is certified and vests in March 2028 if earned, and settles anywhere between 50 and 200 percent of target. Centene has published no vesting schedule for any employee award below the executive tier, and the chief executive's January 2026 grant shows that even within the executive tier the schedules vary, splitting 138,859 units over three years and 69,429 units over five.
Eligibility by hierarchy level
- Formal eligibility under the 2025 plan is broad, covering employees, officers, non-employee directors, consultants and advisors, but selection is entirely at the committee's discretion.
- The correct answer to the question of a minimum band for restricted stock units is that it is not publicly disclosed. Eligibility language is not an entitlement and the 2,650 award-holder count shows how selective the practice is.
- The Employee Stock Purchase Plan is the only clearly broad-based share mechanism, and the only one an employee can size for themselves through a 1 to 10 percent payroll election.
- Vice-president postings do not state an equity grant, so even at the M4 level a candidate cannot read a grant expectation off the public record.
- Executive equity is where the disclosure is complete: the 2025 long-term incentive mix was 60 percent performance share units and 40 percent restricted stock units for every named executive.
Indicative annual grant value by band — St. Louis
| Band | Annual value (USD) | Median | Shares at $65 |
|---|---|---|---|
| E1 | $2.68M – $4.47M | $3.58M | ~41,282–68,804 |
| E2 | $10.02M – $16.70M | $13.36M | ~154,188–256,979 |
| CEO | $11.65M – $19.42M | $15.54M | ~179,282–298,803 |
Annualized planning value (±25%), not the face value of every new-hire grant. Share equivalents use the $65 reference price at 25 August 2026 close and ignore plan valuation rules and PSU performance. Highlighted rows are disclosed grant-date stock awards.
Named executive target equity
| Executive | Target | Units / structure |
|---|---|---|
Sarah M. London Chief Executive Officer | $15,537,733 granted in fiscal 2025 | 60 percent performance share units and 40 percent restricted stock units. The January 2026 award was 520,720 securities: 138,859 three-year units, 69,429 five-year units and 312,432 target performance share units settling 0 to 200 percent through March 2029. |
Andrew L. Asher EVP, Chief Financial Officer | $13,362,923 granted in fiscal 2025 | Same 60/40 mix. The award is close enough to the chief executive's that the CFO row does not read as a step down on equity. |
Christopher A. Koster EVP, Secretary and General Counsel | $5,111,079 granted in fiscal 2025 | Same 60/40 mix, at about a third of the chief executive's grant value. |
Susan R. Smith Chief Operating Officer | $3,577,782 granted in fiscal 2025 | Same 60/40 mix. |
Tanya M. McNally Chief People Officer | $1,967,756 granted in fiscal 2025 | Same 60/40 mix, the smallest disclosed named executive grant for 2025. |
Christopher Neczypor Incoming Chief Financial Officer from 1 January 2027 | $5.25M 2027 long-term incentive target plus a $10.0M make-whole award | The make-whole restricted stock units vest in three equal annual instalments and sit alongside a $2.0 million cash sign-on payment. This is a lateral hiring package, not a standing executive grant level. |
Executive Compensation
Fiscal 2025 named executive compensation from the 2026 definitive proxy statement. Stock awards are grant-date fair values under SEC and FASB rules and may never be realised, so the totals below are accounting values rather than cash received.
Reading the package
Salary was about 7.6 percent of Sarah London's fiscal 2025 reported total and stock awards about 79.7 percent, so the headline number is overwhelmingly an equity instrument. Her total fell about 5.3 percent from $20.602 million in 2024 even though both salary and stock awards rose, because the cash incentive dropped from $4.289 million to $2.109 million when the plan funded at 71.6 percent. Her 2025 approved base of $1,500,000 was a 7 percent increase and her first since 2022.
Centene's $19.506 million sits below Cigna and Elevance and above Molina, which is roughly where its revenue scale would place it among managed-care peers. UnitedHealth's $60.951 million is not comparable because it includes a large one-time option award, and the comparison as a whole is limited by differing fiscal designs, award mixes and accounting treatments across the five proxies.
Named Executive Officers & Board
Centene's disclosed leadership layer is small: five named executive officers for fiscal 2025, plus a chief financial officer succession that spans 2026 and 2027. Everything below that layer is visible only through Section 16 filings and individual job postings.
The 2025 approved base salaries show differentiated market and scope adjustments rather than a single merit grid: London to $1,500,000 at 7 percent, Asher to $1,200,000 at 17 percent, Koster to $775,000 at 3 percent, McNally to $675,000 at 13 percent and Smith to $725,000 at 4 percent. The proxy notes that London, Asher and Koster had not received an increase since 2022 and cites increased scope and market positioning. The incoming chief financial officer's package is the clearest evidence of what lateral executive hiring costs at Centene: $1.1 million base, a 150 percent bonus target capped at 200 percent of target, a $5.25 million 2027 long-term incentive target, $10.0 million of make-whole restricted stock units in three equal annual instalments and a $2.0 million cash sign-on payment.
Board compensation framework
| Element | Amount | Notes |
|---|---|---|
| Annual cash retainer | $120,000 | Increased from $100,000 effective February 2026. |
| Annual restricted stock unit award | $225,000 | Unchanged in the February 2026 update; units generally vest on the first anniversary of grant. |
| Independent chair additional cash | $95,000 | Increased from $90,000 effective February 2026. |
| Independent chair additional restricted stock units | $150,000 | On top of the standard $225,000 director award. |
| Committee chair additional cash | $20,000–$30,000 | Varies by committee; selected committee-chair retainers rose to $25,000 in February 2026. |
Eleven directors held equity awards at 15 March 2025. A director package of $120,000 cash plus $225,000 of restricted stock units is a governance retainer rather than an employment band, and it sits above the analytical M2 director midpoint of about $197,850 despite being part-time work, which is a useful reminder that the word director means two entirely different things in this company.
Regional heads and other officers
No compensation table exists for executives below the named officer tier. The only public number attached to the vice-president layer is the posted salary range on individual requisitions, and in 2026 those ran from $171,900 at the bottom of an associate general counsel range to $431,400 at the top of an interoperability range. Neither posting discloses a bonus target or an equity grant, so the step from M4 to E1 cannot be sized from public evidence.
Insider Trades — SEC Forms 3/4/5
Four Form 4 events between January and August 2026. Two are tax-withholding dispositions on vesting, which are mechanical and should not be read as insider selling; one is a grant; one is a genuine open-market sale.
| Date | Person | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-01-26 | Sarah M. London Chief Executive Officer | Award Includes 138,859 three-year restricted stock units, 69,429 five-year restricted stock units and 312,432 target performance share units settling 0 to 200 percent with certification through March 2029. The Form 4 price field is $0; the value shown is an illustrative mark at the $65.00 reference price, not a grant-date fair value and not a realised amount. | 520,720 | — | $33.85M |
| 2026-03-15 | Andrew L. Asher EVP, Chief Financial Officer | Withholding Code F: shares withheld to satisfy taxes on vesting, not an open-market sale. The $34.45 price is roughly half the August reference price, which is a useful marker of how far the shares moved during 2026. | 15,241 | $34.45 | $525K |
| 2026-06-15 | Susan R. Smith Chief Operating Officer | Withholding Code F: a small tax-withholding disposition on vesting, again not a discretionary sale. | 483 | $65.19 | $31K |
| 2026-08-18 | Christopher A. Koster EVP, Secretary and General Counsel | Sale Code S: a genuine open-market sale at a weighted average price, with individual executions between $65.28 and $65.45. This is the only discretionary disposition in the window and the only one above $3 million. | 47,603 | $65.36 | $3.11M |
Reading guide
Benefits & Perks
Centene's benefits are documented at category level on its official careers pages and almost nowhere at formula level. The categories below are verified; the contribution percentages, premium shares, day counts and reimbursement caps behind them are not published, and this report marks that gap rather than filling it with market norms.
United States
- Health — Medical, dental and vision insurance. Offered to eligible employees. Carrier, employee premium and employer contribution schedule are not publicly itemised in any Centene source. [official]
- Health — Indiana employee ICHRA pilot. About 600 Centene employees are enrolled in an individual marketplace plan through an employee individual coverage health reimbursement arrangement, most choosing Gold or Platinum, with the employer subsidy covering all or most of the employee premium. It is a specific program, not a nationwide contribution formula. [official]
- Protection — Short- and long-term disability. Confirmed as offered. Coverage multiples, elimination periods and premium splits are not disclosed. [official]
- Protection — Supplemental life and accidental death insurance. Confirmed as offered. Multiples of salary and employee cost are not disclosed. [official]
- Retirement — 401(k) with company match and Roth option. The match itself is confirmed on the official benefits page, but the current match percentage and vesting schedule could not be traced to an authoritative plan document. A crowd-reported 50 percent on the first 6 percent is widely repeated and is not treated as verified here. [official]
- Equity — 2002 Employee Stock Purchase Plan. Eligible generally after 90 days. Payroll deductions of 1 to 10 percent buy shares at 95 percent of the closing price on the quarterly exercise date in January, April, July and October, with a $2,500 fair-value cap per quarter and a 90-day holding requirement. [official]
- Spending accounts — Healthcare, dependent-care and commuter flexible spending accounts. Offered. Contribution limits and any employer seeding are not disclosed. [official]
- Time off — Vacation, personal and sick time plus company holidays. Confirmed as offered. The standard day or hour accrual by tenure is not officially published, and crowd-reported hour totals were not promoted to verified terms. [official]
- Family — Birth-parent leave up to 14 weeks. The longest single leave entitlement Centene discloses. Eligibility and pay mechanics are subject to the plan. [official]
- Family — Caregiver leave up to 6 weeks. For care of an immediate family member. Eligibility is subject to the plan. [official]
- Family — Adoption reimbursement and family support. Adoption reimbursement, parenting resources and backup dependent-care references are named on the benefits page; the reimbursement limit is not public. [official]
- Learning — Tuition reimbursement. Confirmed as offered. The annual reimbursement cap is not published. [official]
- Learning — Centene University. An enterprise learning organisation covering leadership, operations, technology, mentoring and career development, described as available to employees including part-time team members. [official]
- Wellbeing — Employee assistance program, wellness and fitness access. An employee assistance program plus wellness programming and fitness-centre or discount access at many locations. Availability varies by site. [official]
- Work model — Remote, hybrid, field and office schedules. The 10-K describes a majority remote or hybrid workforce, and every 2026 posting cited in this report is advertised as remote or hybrid. It is a role-dependent arrangement, not a universal entitlement. [official]
- Community — Paid volunteer opportunities. Named on the official benefits summary. The annual hour allowance is not stated. [official]
Global programs
- Enterprise — Centene University and development programs. Described as available across the enterprise, including part-time team members, with programs spanning leadership, operations, technology, mentoring and career development plus selected external development collaborations. [official]
- Enterprise — Culture survey and employee networks. More than 35,000 employees took part in the 2025 annual culture survey and nearly 90 percent participated in at least one survey or engagement instrument. Employee professional networks are described but not enumerated. [official]
- Enterprise — Internal mobility and succession. Centene reports that 43 percent of vice-president and above openings were filled internally in 2025, and that succession plans were delivered for 30 critical roles and 30 additional key-talent roles. [official]
- Outside the United States — India. No current Centene India employing entity or benefits schedule was verified, so employer provident fund contribution, gratuity policy, group medical and term life cover, leave entitlements, maternity and paternity policy, meal and transport allowances and relocation support are all not applicable on the evidence available. Indian statutory minimums are not substituted for company policy here. [npd]
- Outside the United States — Australia and New Zealand. No current employing footprint was verified, so company-specific superannuation, leave, private health cover, salary packaging and wellness terms are not disclosed. [npd]
- Outside the United States — United Kingdom and Europe. Circle Health Group was sold in January 2024 and the Spanish and Central European operations were divested earlier, so legacy hospital and clinic benefits must not be presented as current Centene benefits. [npd]
Benefit fields not publicly quantified
Centene shows only one benefit region in this report because the operating-footprint review verified only one. The gaps inside that region are real and specific: the 401(k) match formula and vesting schedule, the paid-time-off day count by tenure, the employer share of medical premiums, the tuition reimbursement cap, the adoption reimbursement limit and the volunteer hour allowance are all confirmed to exist and none is published. Employee-reported figures circulate for several of these and are deliberately not promoted to verified plan terms.
Performance Review & Pay Progression
Centene describes a pay-for-performance philosophy, performance reviews at key milestones, culture and engagement monitoring and succession planning for critical roles. It publishes no rating scale, no distribution and no merit matrix for general employees, and this report shows that absence rather than manufacturing a grid.
Not publicly disclosed
Modeled promotion planning timeline
| Band | Years to next scope | Promotion hike | Status |
|---|---|---|---|
| C1 | Not publicly disclosed | Not disclosed | Modeled planning interval |
| C2 | Not publicly disclosed | Not disclosed | Modeled planning interval |
| C3 | Not publicly disclosed | Not disclosed | Modeled planning interval |
| M1 | Not publicly disclosed | Not disclosed | Modeled planning interval |
| C4 | Not publicly disclosed | Not disclosed | Modeled planning interval |
| M2 | Not publicly disclosed | Not disclosed | Modeled planning interval |
| M3 | Not publicly disclosed | Not disclosed | Modeled planning interval |
| M4 | Not publicly disclosed | Not disclosed | Modeled planning interval |
| E1 | Appointment, not promotion; depends on succession planning and board approval | Not disclosed | Modeled planning interval |
| E2 | Appointment, not promotion; succession announced for 1 January 2027 | Not disclosed | Modeled planning interval |
| CEO | Board appointment | Not disclosed | Modeled planning interval |
The only quantified internal progression evidence Centene publishes is at the top of the house: 43 percent of vice-president and above openings were filled internally in 2025, succession plans were delivered for 30 critical roles and 30 additional key-talent roles, more than 35,000 employees took the annual culture survey and nearly 90 percent engaged with at least one instrument. These show an active talent process. They reveal nothing about promotion odds, calibration or pay outcomes below the executive layer.
Pay progression evidence
The 2025 named executive base increases of 3, 4, 7, 13 and 17 percent are the only pay-progression numbers in the public record, and their spread is the point: they reflect role scope, time in position, individual performance, leadership potential, internal benchmarking and peer market data rather than a single merit grid. Nothing in the filings suggests those percentages apply to the broader workforce, and the 2026 voluntary separation program makes any assumption of a routine annual merit cycle for 2026 unsafe.
H-1B / LCA Visa Footprint — United States
Centene is a small, technology-concentrated visa sponsor rather than a bulk filer. Roughly a hundred labour condition applications a year, clustered in St. Louis and Tampa, give the only city-level wage evidence that exists for the company. These are offered base wages and exclude bonus, equity and benefits entirely.
Dataset summary
| Dataset | Result | Interpretation |
|---|---|---|
| h1bdata.info, 2025 employer records | 96 displayed records, median $138,136.565 | Rows are filings or positions rather than unique workers, and the site's year filter is calendar based. |
| MyVisaJobs employer summary, updated 18 August 2026 | 115 certified FY2025 applications, average $137,841 | Adds 1 withdrawn and 25 certified-withdrawn filings, and separately reports USCIS petition decisions. |
| MyVisaJobs FY2026 partial | 86 filings, 38 approvals and 1 denial | Partial-year data that is not comparable with a completed fiscal year. |
City-level H-1B wage history
| City | P25 | Median | P75 | Records |
|---|---|---|---|---|
St. Louis, MO The headquarters market and the largest sample in the file, which is why it anchors this report. | $132K | $140,306 | $146K | 24 |
Tampa, FL Legacy WellCare technology hub; the median sits within 1 percent of St. Louis. | $140K | $141,267 | $153K | 9 |
Wesley Chapel, FL Small sample and the highest Florida wages in the file, about 19 percent above the anchor. | $149K | $166,521 | $171K | 5 |
Folsom, CA Small sample and the highest observed wage level, about 30 percent above the anchor. | $174K | $182,411 | $191K | 4 |
Irving, TX Small sample and the lowest observed wage level, about 9 percent below the anchor. | $117K | $128,000 | $133K | 4 |
All-years aggregates. P25/P75 are rounded reconstruction values marked modeled; medians and record counts are the stronger fields.
Selected title / worksite records
| Title | Worksite | Proffered wage | Notes |
|---|---|---|---|
| Business Analyst II | Irving, TX | $82,650 | Sits inside the analytical C2 envelope and is the lowest named example in the file. |
| Data Analyst IV | Indianapolis, IN | $131,330 | Close to the C3 senior professional midpoint of about $113,950 and inside the posted senior analyst range. |
| Lead Application Development Engineer | St. Louis, MO | $143,750–$160,496 | Multiple displayed records at the headquarters site, mapping to the C4 lead and principal band. |
| Lead Data Engineer | Tampa, FL | $141,267 | The Tampa median is set by roles of exactly this type, which is why the Tampa factor tracks St. Louis so closely. |
| Director, Information Technology | Tampa, FL | $207,041 | The highest named example and a direct cross-check on the M2 director envelope of $121,500 to $274,200. |
| Director of Operations | Bridgeville, PA | $180,000 | A non-technology director at a small worksite, showing the M2 spread is functional rather than geographic. |
Reading the data correctly
- These are offered base wages attached to labour condition applications. They exclude bonus, equity, benefits and any allowance, so they are a floor on cash rather than a package.
- The two datasets disagree on the 2025 count, 96 against 115. The likely causes are fiscal versus calendar filters, employer-name matching, certification status, duplicate and amended filings and refresh timing. Neither number is a count of employees hired.
- Visa filings overrepresent sponsored occupations. Technology, analytics and actuarial roles dominate the file, and no frontline care coordination, member services or clinical role appears in it at all.
- Three of the five city samples rest on four or five records, so the Folsom, Wesley Chapel and Irving factors in this report should be read as directional observations rather than city pay policies.
- A single worker can appear as several filings across amendments, extensions and transfers, so record counts overstate distinct individuals.
Key Nuances & Insights
Centene publishes a salary range on each requisition and nothing else. No grade numbering, no midpoints, no compa-ratio, no range penetration, no job-family point system. C1 to C4 and M1 to M4 exist only in this report. The practical consequence is that a candidate cannot ask where in the band an offer sits, because there is no band to sit in, only the posted range for that specific requisition.
The 2026 Associate General Counsel range tops out at $326,900, Network Development at $343,300 and Interoperability Strategy at $431,400. Title is not the pricing unit at Centene; function and remit are. Any inference of a corporate vice-president midpoint from one or two postings is unsafe by a six-figure margin.
The 2025 Stock Incentive Plan permits awards to employees, officers, directors, consultants and advisors, yet only about 2,650 employees plus 11 directors held awards at 15 March 2025 against a 61,100 year-end workforce. Roughly 4.3 percent. The honest answer to the question of a minimum band for restricted stock units is that it is not publicly disclosed, and eligibility language should never be read as an expectation.
Shares are purchased at 95 percent of the closing price on the quarterly exercise date. There is no offering-period lookback, no reset feature and no purchase at the lower of two prices, which is what makes the technology-sector plans valuable. Centene's is a modest, reliable benefit with a $2,500 quarterly fair-value cap and a 90-day holding rule, and it is still the only equity most employees will ever receive from the company.
The plan funded at 71.6 percent of target for every named executive, cutting the chief executive's cash incentive from $4.289 million to $2.109 million year on year and dragging her total down 5.3 percent even though salary and stock awards both rose. This is the clearest available evidence that Centene's committee funds on the corporate result rather than smoothing outcomes.
For 2026 the 20 percent organic premium and service revenue weighting is replaced by a 20 percent Health Benefits Ratio measure, and the long-term incentive design shifts toward absolute total shareholder return. Both changes tie executive pay more tightly to medical cost control and to the share price itself, which matters after a year in which Marketplace membership fell.
Salary was 7.6 percent of the fiscal 2025 total. That makes the headline number a grant-date accounting valuation rather than money received, and it makes the reported figure highly sensitive to valuation assumptions, performance certification and the share price. Actual value realised on vesting in 2025 was $5,799,725, less than a third of the reported total.
Christopher Neczypor's disclosed terms are $1.1 million base, a 150 percent bonus target, a $5.25 million 2027 long-term incentive target, $10.0 million of make-whole restricted stock units in three annual instalments and a $2.0 million cash sign-on. The make-whole award alone is nine times base salary. It replaces forfeited equity at a prior employer and establishes nothing about a general lateral premium at any other level.
Two of the four 2026 Form 4 events are code F tax withholdings on vesting, where the executive controls neither the timing nor the size. Only Koster's August 2026 sale of 47,603 shares for about $3.11 million is a discretionary open-market disposition. Screening tools that lump the two together will misread Centene's insider activity badly.
Asher's March 2026 tax withholding priced at $34.45 and Smith's June withholding at $65.19, against a $65.00 reference close on 25 August 2026. Employees holding unvested restricted stock units through that window saw the value of an identical unit count move dramatically, which is exactly the risk a grant-date accounting figure conceals.
The research bundle carried selectors for Bangalore, Chennai, Hyderabad, Sydney, Manila, Auckland, Singapore and Dubai and found no current Centene employing entity behind any of them. Converting a St. Louis salary into rupees produces a rupee number, not an India salary, and vendor or business-process outsourcing personnel are not Centene employees without an employing-entity source.
The 67,700 team members reported at the end of 2023 included roughly 8,300 Circle Health employees in a United Kingdom hospital business sold in January 2024 for about $931 million. On a comparable basis the 2023 figure is closer to 59,400, so the true trajectory is 59,400 to 60,500 to 61,100, mild growth rather than the 10 percent collapse the raw numbers suggest.
Broad buyout eligibility was confirmed in June 2026 after Marketplace membership losses, a voluntary separation program commenced on 27 July, and the Q2 10-Q estimates $315 million to $365 million of severance expense for the remainder of the year. None of this is a salary cut, but it changes retention economics, open requisition volume and bargaining leverage in ways a static salary table cannot show.
A non-employee board member receives $120,000 in cash plus $225,000 in restricted stock units for part-time governance work, a $345,000 package. The analytical M2 Director band, a full-time operating role, has a midpoint of about $197,850. The word means two completely different things inside the same company.
Research control
On chief executive pay Centene sits fourth of five in its managed-care comparison set, below Cigna at $22.866 million and Elevance at $22.582 million, above Molina at $18.341 million and far below UnitedHealth's $60.951 million, which carries a large one-time option award. Its 206 to 1 ratio is a function of a $94,800 median employee, a figure that reflects a workforce weighted toward care coordination, member services and claims rather than toward engineering. On the employee side, the C1 to M4 ladder is a base-salary market map with no visible bonus or equity layer, which is the structural difference between a managed-care payer and the technology employers most compensation benchmarks are built around.
Evidence classification
| Label | Meaning | Examples and permitted use |
|---|---|---|
| Verified | A Centene SEC filing, a filed plan exhibit, an official Centene job posting or an official Centene benefits page. | Executive pay, the pay ratio, equity plan mechanics, ESPP terms, benefit categories, headcount, board pay and every band's posted salary endpoints. |
| Reported | A named third-party dataset with observable records, chiefly the 2025 labour condition application files and, for directional checks only, salary platforms. | City wage percentiles, the four city calibration factors and the role-level cross-checks against the analytical bands. |
| Modeled | An arithmetic midpoint across official postings, or the St. Louis midpoint scaled by an observed city factor, shown inside a planning envelope. | The C2 through M4 band midpoints, which join several distinct roles, and every city cell outside St. Louis. |
| Not publicly disclosed | No source in the research bundle supports a figure, and none is estimated. | Every employee bonus target, every employee equity grant value, the 401(k) match formula, the rating scale and the merit matrix. |
Explicit “Not publicly disclosed” index
Known gaps and diligence before relying on a cell
- 1The three executive rows are kept inside the band table but are marked chart-excluded, and because every priced market in this report is in the United States at a fixed factor there is no seniority interpolation anywhere. No offshore cell is therefore distorted by a global executive figure, which is the usual failure mode when proxy rows sit in an employee ladder.
- 2Bonus and equity are recorded as zero for every band from C1 through M4, so total compensation equals base salary for those rows. That is a disclosure gap, not a finding that Centene pays no bonus. Postings state that additional incentives may apply and give no way to size them.
- 3No employer benefit load is added to any total in this report. Centene's benefits are economically material but cannot be valued from public plan summaries, and adding a notional 8 to 15 percent would convert employer cost into pay.
- 4Seventeen of the twenty-one markets sit at the anchor factor of 1.00 because no wage observation exists for them. This reflects Centene's own stated position that pay is set by the posting rather than by the city, and it should not be read as a finding that Sacramento and Great Falls pay the same.
- 5The two visa datasets disagree on the 2025 count, 96 displayed records against 115 certified applications, and this report presents both rather than reconciling them, because labour condition applications, prevailing-wage requests and petitions are different processes with different denominators.
- 6The chief executive pay ratio uses $19,516,298 while the Summary Compensation Table shows $19,506,298. The $10,000 difference is a medical benefits adjustment inside the ratio calculation and both figures are disclosed as filed.
- 7The 2,650 award-holder count is dated 15 March 2025 while the 61,100 headcount is dated 31 December 2025. The resulting 4.3 percent participation figure is indicative only.
- 8The equity plan tables cannot yield a single pool utilisation rate, because authorised shares, outstanding full-value awards, legacy assumed awards and future availability do not share a common denominator across the plans they cover.
- 9A crowd-reported 401(k) match of 50 percent on the first 6 percent could not be traced to a current authoritative plan document and is excluded from the verified benefit rows.
- 10The board retainer increase is dated to February 2026 in the proxy without a day, and the news entry carries the first of that month as a placeholder date.
- 11Approximate 2025 revenue of about $195 billion appears in the bundle without a filing citation and is therefore not carried in any metric in this report.
- 12No exchange rate other than USD is used anywhere, because no Centene pay in any other currency was verified. The bundle's own report-date table of INR 95.4191, AUD 1.3924, GBP 0.7334, EUR 0.8573, PHP 61.5706, NZD 1.6792, SGD 1.2700 and AED 3.6725 per US dollar is recorded here for completeness only.
Source register — 42 sources
| S1 | 2025 Form 10-K, year ended 31 December 2025 · US Securities and Exchange Commission / Centene · 2025-12-31. 61,100 team members, workforce philosophy, benefit categories, equity accounting, subsidiary and divestiture context, ESPP balances |
| S2 | 2026 definitive proxy statement · US Securities and Exchange Commission / Centene · 2026-03-26. Fiscal 2025 named executive pay, pay ratio, incentive targets and 71.6 percent funding, LTI mix, director pay, internal-fill statistic, ICHRA pilot |
| S3 | 2025 definitive proxy and 2025 Stock Incentive Plan proposal · US Securities and Exchange Commission / Centene · 2025-03-27. Plan award types, 15,000,000 share authorisation, minimum vesting, and the 2,650 employee plus 11 director award-holder count |
| S4 | 2024 Form 10-K · US Securities and Exchange Commission / Centene · 2024-12-31. 60,500 headcount and the Circle Health disposal context |
| S5 | 2023 Form 10-K · US Securities and Exchange Commission / Centene · 2023-12-31. 67,700 headcount including roughly 8,300 Circle Health employees |
| S6 | Q2 2026 Form 10-Q, quarter ended 30 June 2026 · US Securities and Exchange Commission / Centene · 2026-06-30. Voluntary separation program from 27 July 2026 and the $315 million to $365 million severance estimate |
| S7 | Form 8-K on chief financial officer succession · US Securities and Exchange Commission / Centene · 2026-08-12. Neczypor base, bonus target, 2027 LTI target, make-whole restricted stock units and cash sign-on |
| S8 | 2002 Employee Stock Purchase Plan, filed exhibit · US Securities and Exchange Commission / Centene · 2019-06-30. ESPP eligibility, contribution range, quarterly offering mechanics, 95 percent purchase price and holding rule |
| S9 | 2020 ESPP amendment · US Securities and Exchange Commission / Centene · 2020-04-30. ESPP amendment history and reserved-share changes |
| S10 | Care Coordinator III posting, Bedford and remote New Hampshire · Centene Careers · 2026-08-21. $20.39 to $34.71 an hour and the two-to-four-year experience clue behind the C2 floor |
| S11 | Senior Business Technical Analyst posting, remote Missouri · Centene Careers · 2026-07-11. $87,700 to $157,800, the primary C3 anchor |
| S12 | Senior Business Solutions Architect posting, remote Florida · Centene Careers · 2026-07-14. $107,700 to $199,300, the C4 floor |
| S13 | Vice President, Network Development and Contracting posting, remote Michigan · Centene Careers · 2026-05-18. $180,400 to $343,300 vice-president anchor |
| S14 | Vice President, Interoperability Strategy and Operations posting, remote North Carolina · Centene Careers · 2026-08-25. $227,700 to $431,400, the M4 ceiling and the most recent posting in the set |
| S15 | Life at Centene benefits page · Centene Careers · 2026-08-26. Medical, disability, 401(k) match, ESPP, leave, tuition, Centene University and flexible work categories |
| S16 | Culture, talent and well-being page · Centene · 2026-08-26. Centene University reach, workforce development, internal mobility and employee networks |
| S17 | Centene Management Company LLC 2025 records · h1bdata.info · 2026-08-26. 96 displayed records, $138,137 median, wage distribution, city quartiles and role examples |
| S18 | Centene Management employer summary, FY2023 to FY2026 · MyVisaJobs · 2026-08-18. Certified application counts, petition approvals and denials, and annual average wages |
| S19 | Report on Centene buyout offers after Marketplace losses · Reuters · 2026-06-15. Broad buyout eligibility, about 61,000 employees at the end of Q1 2026, commercial revenue down 6 percent and membership around 26.3 million |
| S20 | Daily exchange rates table · Reserve Bank of Australia · 2026-08-26. The report-date foreign-exchange convention recorded in known gaps; no Centene pay is converted |
| S21 | Form 4, Sarah London award of 520,720 securities · US Securities and Exchange Commission · 2026-01-26. RSU and PSU tranches, vesting and certification through March 2029 |
| S22 | Form 4, Andrew Asher code F disposition · US Securities and Exchange Commission · 2026-03-15. 15,241 shares withheld at $34.45 for taxes on vesting |
| S23 | Form 4, Susan Smith code F disposition · US Securities and Exchange Commission · 2026-06-15. 483 shares withheld at $65.19 for taxes on vesting |
| S24 | Form 4, Christopher Koster code S sale · US Securities and Exchange Commission · 2026-08-18. 47,603 shares sold at a weighted average $65.36 with executions from $65.28 to $65.45 |
| S25 | Elevance Health 2026 definitive proxy · US Securities and Exchange Commission / Elevance Health · 2026-03-26. Gail Boudreaux fiscal 2025 total compensation of $22.582 million |
| S26 | The Cigna Group 2026 definitive proxy · US Securities and Exchange Commission / The Cigna Group · 2026-03-12. David Cordani fiscal 2025 total compensation of $22.866 million |
| S27 | Molina Healthcare 2026 definitive proxy · US Securities and Exchange Commission / Molina Healthcare · 2026-03-13. Joseph Zubretsky fiscal 2025 total compensation of $18.341 million |
| S28 | UnitedHealth Group 2026 definitive proxy · US Securities and Exchange Commission / UnitedHealth Group · 2026-04-01. Stephen Hemsley fiscal 2025 total of $60.951 million including a large one-time option award |
| S29 | Historical market data, 25 August 2026 close · Centene Investor Relations · 2026-08-25. The $65.00 reference price used only for clearly labelled illustrative valuations |
| S30 | Report on a reduction of about 2,000 jobs · Reuters · 2023-09-26. The 2023 restructuring that complicates raw headcount comparisons |
| S32 | Centene software engineer salary page · Levels.fyi · 2026-08-26. Directional check on C2 to C4, showing roughly $78,000 to $156,000 and a displayed median package around $130,000 |
| S33 | Centene Director salary page · Glassdoor · 2026-08-26. Directional check on M2, showing an estimated average around $219,700 and submissions from roughly $148,000 to $246,000 |
| S34 | Centene Corporation employer salary page · PayScale · 2026-05-28. Broad sanity check at an $81,598 company average across a 297-report sample |
| S35 | Centene role salary pages · Indeed · 2026-08-26. Directional title checks at about $144,700 for Director, $129,000 for Manager, $80,400 for Data Analyst and $126,600 for Senior Software Engineer |
| S36 | Director of Operations salary estimate · Comparably · 2026-08-26. The only public bonus split for a non-executive role, at $154,755 base plus $29,726 bonus, treated as directional only |
| S37 | Care Coordinator II posting · Centene Careers · 2026-08-14. $17.84 to $28.02 an hour, the C1 frontline anchor |
| S38 | Principal Incident Response Analyst posting · Centene Careers · 2026-07-14. $121,500 to $224,900, the C4 ceiling |
| S39 | Manager, Provider Data Management posting · Centene Careers · 2026-08-24. $70,100 to $126,200, the lower M1 manager anchor |
| S40 | Senior Manager, Product Performance posting · Centene Careers · 2026-08-25. $107,700 to $199,300, the upper M1 anchor |
| S41 | Senior Director, Healthcare Analytics posting · Centene Careers · 2026-08-20. $134,600 to $249,000, the lower M3 anchor |
| S42 | Senior Director, Pharmacy posting · Centene Careers · 2026-08-12. $185,700 to $352,500, the upper M3 anchor with California and licensed-clinical scope |
| S43 | Vice President, Associate General Counsel posting · Centene Careers · 2026-08-17. $171,900 to $326,900, the lower M4 anchor |
Recent News & Workforce Trend
Centene's 2026 has been dominated by workforce reduction and a chief financial officer succession rather than by a pay increase. No companywide salary action was announced in any reviewed source, and the only enterprise-scale compensation event on record is severance.
On a comparable basis Centene has been broadly flat at just under 61,000 people for three years, and the apparent 2023 to 2024 collapse is an artefact of divesting a hospital business rather than a reduction in the core workforce. That flat line is about to break: the voluntary separation program that commenced on 27 July 2026 carries $315 million to $365 million of estimated severance expense for the remainder of the year, and no audited year-end 2026 count exists yet. Centene reports total team members only, with no split by office, state, country or function.
Christopher Koster disposed of 47,603 shares at a weighted average $65.36, about $3.11 million, with executions between $65.28 and $65.45. It is the only discretionary insider sale in the 2026 window and came three weeks after the voluntary separation program commenced.
Andrew Asher will retire as chief financial officer on 31 December 2026 and serve as strategic advisor through 2027. Christopher Neczypor joins as executive vice president around 1 September 2026 and becomes chief financial officer on 1 January 2027 on $1.1 million base, a 150 percent bonus target capped at 200 percent of target, a $5.25 million 2027 long-term incentive target, $10.0 million of make-whole restricted stock units in three equal annual instalments and a $2.0 million cash sign-on payment.
The Q2 2026 Form 10-Q records vendor and severance optimisation costs and estimates $315 million to $365 million of severance expense for the remainder of 2026. It is the largest single compensation-related number Centene disclosed in 2026.
Centene confirmed separation-package eligibility for most staff following Marketplace membership losses. Contemporaneous reporting put commercial revenue down 6 percent in the first quarter, total health-plan membership around 26.3 million and headcount around 61,000.
Every named executive was paid at 71.6 percent of target with no individual adjustment, cutting the chief executive's cash incentive to $2,109,446 from $4,289,000 a year earlier. The same filing discloses the 206 to 1 pay ratio against a $94,800 median employee and confirms the 2026 shift to a Health Benefits Ratio metric.
Effective February 2026 the annual cash retainer rose from $100,000 to $120,000, the independent chair's additional cash from $90,000 to $95,000 and selected committee-chair retainers to $25,000. The $225,000 annual restricted stock unit award was left unchanged. The proxy gives the month without a day.
Sarah London's award comprised 138,859 three-year restricted stock units, 69,429 five-year restricted stock units and 312,432 target performance share units settling between zero and 200 percent, with certification and vesting running through March 2029.
The 10-K reports 61,100 team members, $204 million of 2025 stock compensation expense with $356 million unrecognised over about 2.1 years, roughly 8.836 million restricted stock units granted against 2.593 million vested, and 2,129,451 ESPP shares remaining after about 796,000 were issued during the year.
The plan was approved during 2025 with 15,000,000 shares initially authorised, permitting options, stock appreciation rights, restricted stock, restricted stock units, performance share units and other stock-based awards under a one-year minimum vesting rule with limited exceptions.
The plan proposal discloses roughly 2,650 employee award-holders plus 11 directors at this date, against a workforce that closed the year at 61,100. It is the single clearest measure of how selective Centene's employer-granted equity is.
The United Kingdom hospital business, which carried roughly 8,300 employees, was sold. Together with earlier Spanish and Central European divestitures it removed the last material non-United States employing footprint from the group.
The reduction predates the Circle Health divestiture and is one of two structural changes that make raw year-on-year headcount comparisons for 2023 and 2024 unreliable.